BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
nitric oxide metabolic process
,
Leukemia
,
Prostate
,
Pharmacogenetics
,
Aspirin
,
FGF21
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
benzyloxycarbonylvalyl alanyl- aspartyl fluoromethyl ketone
Summary
General Info
Curated Studies
Most Correlated Studies
Breast epithelial cells surviving treatment with TRAIL
Acute myeloblastic leukemia Kasumi-1 cells expressing RUNX1-RUNX1T1 (AML1-ETO) or RUNX1 siRNA
Explore Curated Studies Results
Literature
Most Relevant Literature
Cellular autophagy, an unbidden effect of caspase inhibition by zVAD-fmk.
Off-target inhibition of NGLY1 by the polycaspase inhibitor Z-VAD-fmk induces cellular autophagy.
Ferrostatin-1 and Z-VAD-FMK potentially attenuated Iron-mediated neurotoxicity and rescued cognitive…
Inhibition of elicitation of allergic contact dermatitis by topical use of Z-VAD-FMK, a broad caspas…
Role of HMGB1 in TNF-α Combined with Z-VAD-fmk-Induced L929 Cells Necroptosis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for benzyloxycarbonylvalyl alanyl- aspartyl fluoromethyl ketone
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ